Filing Details

Accession Number:
0000950170-25-021210
Form Type:
13G Filing
Publication Date:
2025-02-13 19:00:00
Filed By:
Maverick Capital
Company:
Wave Life Sciences Ltd.
Filing Date:
2025-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Maverick Capital, Ltd. 0 8,261,242 5.4%
Maverick Capital Management, LLC 0 8,261,242 5.4%
Lee S. Ainslie III 0 8,261,242 5.4%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Maverick Capital, Ltd.
 
Signature:/s/ Trevor Wiessmann*
Name/Title:By: Maverick Capital Management, LLC, its General Partner By: Lee S. Ainslie III, Manager
Date:02/14/2025
 
Maverick Capital Management, LLC
 
Signature:/S/ Trevor Wiessmann*
Name/Title:Lee S. Ainslie III, Manager
Date:02/14/2025
 
Lee S. Ainslie III
 
Signature:/S/ Trevor Wiessmann*
Name/Title:Lee S. Ainslie III, Manager
Date:02/14/2025

Comments accompanying signature:  *Under Power of Attorney, dated March 15, 2018